Sort
78,016 grants matching “breast cancer”
Creation of in vivo active chemical probes for CAMKK2 to treat cancer
$649,225David Harold Drewry · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA
IOWA ONCOLOGY RESEARCH ASSOCIATION
$649,206Iowa Oncology Research Association · U10 · FY2004 · CA
Dynamics in the Tissue State: From Normal to Tumor and Back
$649,167Jan T. Liphardt · University Of California Berkeley · U54 · FY2010 · CA
Caregiver Coping Skills training for Lung Cancer
$649,161Duke University · R01 · FY2004 · CA
Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline
$649,152Mina S Sedrak · University Of California Los Angeles · R01 · FY2024 · CA
Biomaterials (Mf/Zn/F-BCPs) for osteoporosis therapy
$649,067Racquel Z Legeros · New York University · R01 · FY2008 · AR
Human Monoclonal Antibodies Against Cancer
$649,065Dimiter S Dimitrov · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers
$649,046Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Project 2: Splicing Dysregulation in Cancer
$648,960Adrian R Krainer · Cold Spring Harbor Laboratory · P01 · FY2025 · CA
Project 2: Splicing Dysregulation in Cancer
$648,960Adrian R Krainer · Cold Spring Harbor Laboratory · P01 · FY2023 · CA
Clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian cancer
$648,957Elizabeth Mary Swisher · University Of Washington · R01 · FY2025 · CA
Clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian cancer
$648,956Elizabeth Mary Swisher · University Of Washington · R01 · FY2023 · CA
Early detection of treatment response in myelofibrosis by polarization-sensitive mid-infrared spectroscopic imaging
$648,882Rohith Reddy · University Of Houston · R01 · FY2025 · HL
Night Shift Work and Hormone Levels in Men
$648,881Scott Davis · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
NANOFORMULATIONS AND SUSTAINED DELIVERY OF PARP INHIBITORS FOR BREAST CANCER
$648,819Northeastern University · · FY2016 · Department of the Army
Stem Cell Based Soft Tissue Reconstruction
$648,784Jeremy J. Mao · Columbia University Health Sciences · R01 · FY2007 · EB
Developmental Exposures, Stem Cell Reprogramming, and Breast Cancer Disparities
$648,771Justin Adam Colacino · University Of Michigan At Ann Arbor · R01 · FY2023 · ES
Risk prediction methods
$648,755Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
CCOP--Colorado Cancer Research Program
$648,751Colorado Cancer Research Program, Inc. · U10 · FY2002 · CA
Project 2: Regulation of Pre-mRNA Splicing in Tumorigenesis
$648,714Adrian R Krainer · Cold Spring Harbor Laboratory · P01 · FY2019 · CA
Ecology and Evolution of Breast Carcinogenesis
$648,685Mehdi Damaghi · State University New York Stony Brook · U01 · FY2023 · CA
Radiomics and Pathomics to predict upstaging of DCIS
$648,573Bethany Lynn Niell · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Advanced PET/CT Imaging for Improving Clinical Trials
$648,569Paul E Kinahan · University Of Washington · U01 · FY2017 · CA
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'
$648,503Lee W Jones · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Tumor microenvironmental biomarkers of breast cancer invasion
$648,428Robert B West · Stanford University · R01 · FY2025 · CA